Ahern T, Tobin AM, Corrigan M, et al
The significant correlation between the %WR with glucose postprandial excursion but not with insulin/C-peptide postprandial profiles suggests that individuals with higher %WR face an additional challenge to control glucose levels after meals, unsurprisingly given the well-known association of obesity with increased risk of dysglycemia ( We found significantly higher glucose and lower insulin excursions in the T2D relapse subgroup when compared to the T2D remission subgroup
In addition, it may be added to breakfast cereals, alternative milk beverages and other food products
Headaches: Some users report mild headaches, especially when starting supplementation
Pros: Insurance may be accepted Can lower costs significantly for eligible members Multiple medication options Compounded and brand-name GLP-1s, plus non-GLP-1 options Includes a health coaching program Support from a personal health coach and in-app guidance MetabolicPrint feature Helps uncover biological factors affecting weight loss Option for needle-free compounded semaglutide Available in all 50 states Cons: Pricing varies Monthly membership fees and medication costs depend on insurance coverage Medication availability depends on location Not all states allow access to compounded GLP-1s Brand-name GLP-1s may be expensive without insurance Cash prices range from $650-$1500 per month No flat-fee pricing for compounded medications Costs can change over time Take Found Assessment (3 minutes) Which Should You Choose: Mochi, RemedyMeds or Found
Among patients who switched to a different GLP-1 RA medication, many of them switched from dulaglutide labeled for T2D (26.1%) or semaglutide labeled for T2D (21.0%)
